Home ›
Ovarian Cancer Trials ›
NCT04710797
Lymphadenectomy in Early Ovarian Cancer
To assess the impact of comprehensive staging surgery with no lymphadenectomy on survival and quality of life in patients with early-stage ovarian cancer.
Trial Details
NCT ID NCT04710797
Phase NA
Sponsor Sun Yat-sen University
Status RECRUITING
Cancer Type Ovarian Cancer
Interventions Completion staging surgery including systematic pelvic and para-aortic lymphadenectomy Comprehensive staging surgery with no Lymphadenectomy
Locations (sample) Guangzhou, Guangdong, China|23.11667,113.25
Key Eligibility Criteria
Women aged 18 years to 70 years. Primary diagnosis of epithelial ovarian cancer FIGO stage IA-IIA ( recevive no prior treatment or receive incomplete initial surgery),with indicati… Patients who have given their signed and written informed consent. Good performance status (ECOG 0/1).
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Ovarian Cancer Trials on Trialify →